These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 31739603)
1. The Hypervariable Region of K-Ras4B Governs Molecular Recognition and Function. Abdelkarim H; Banerjee A; Grudzien P; Leschinsky N; Abushaer M; Gaponenko V Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739603 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of membrane binding of small GTPase K-Ras4B farnesylated hypervariable region. Jang H; Abraham SJ; Chavan TS; Hitchinson B; Khavrutskii L; Tarasova NI; Nussinov R; Gaponenko V J Biol Chem; 2015 Apr; 290(15):9465-77. PubMed ID: 25713064 [TBL] [Abstract][Full Text] [Related]
3. The hypervariable region of K-Ras4B is responsible for its specific interactions with calmodulin. Abraham SJ; Nolet RP; Calvert RJ; Anderson LM; Gaponenko V Biochemistry; 2009 Aug; 48(32):7575-83. PubMed ID: 19583261 [TBL] [Abstract][Full Text] [Related]
4. Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site. Mazhab-Jafari MT; Marshall CB; Smith MJ; Gasmi-Seabrook GM; Stathopulos PB; Inagaki F; Kay LE; Neel BG; Ikura M Proc Natl Acad Sci U S A; 2015 May; 112(21):6625-30. PubMed ID: 25941399 [TBL] [Abstract][Full Text] [Related]
5. Flexible-body motions of calmodulin and the farnesylated hypervariable region yield a high-affinity interaction enabling K-Ras4B membrane extraction. Jang H; Banerjee A; Chavan T; Gaponenko V; Nussinov R J Biol Chem; 2017 Jul; 292(30):12544-12559. PubMed ID: 28623230 [TBL] [Abstract][Full Text] [Related]
6. The disordered hypervariable region and the folded catalytic domain of oncogenic K-Ras4B partner in phospholipid binding. Banerjee A; Jang H; Nussinov R; Gaponenko V Curr Opin Struct Biol; 2016 Feb; 36():10-7. PubMed ID: 26709496 [TBL] [Abstract][Full Text] [Related]
7. GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (HVR)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site. Lu S; Banerjee A; Jang H; Zhang J; Gaponenko V; Nussinov R J Biol Chem; 2015 Nov; 290(48):28887-900. PubMed ID: 26453300 [TBL] [Abstract][Full Text] [Related]
9. Structure and function of the C-terminal hypervariable region of K-Ras4B in plasma membrane targetting and transformation. Welman A; Burger MM; Hagmann J Oncogene; 2000 Sep; 19(40):4582-91. PubMed ID: 11030147 [TBL] [Abstract][Full Text] [Related]
10. Expression, purification, and characterization of soluble K-Ras4B for structural analysis. Abraham SJ; Muhamed I; Nolet R; Yeung F; Gaponenko V Protein Expr Purif; 2010 Oct; 73(2):125-31. PubMed ID: 20566322 [TBL] [Abstract][Full Text] [Related]
11. K-Ras4B lipoprotein synthesis: biochemical characterization, functional properties, and dimer formation. Dementiev A Protein Expr Purif; 2012 Jul; 84(1):86-93. PubMed ID: 22569482 [TBL] [Abstract][Full Text] [Related]
12. High-Affinity Interaction of the K-Ras4B Hypervariable Region with the Ras Active Site. Chavan TS; Jang H; Khavrutskii L; Abraham SJ; Banerjee A; Freed BC; Johannessen L; Tarasov SG; Gaponenko V; Nussinov R; Tarasova NI Biophys J; 2015 Dec; 109(12):2602-2613. PubMed ID: 26682817 [TBL] [Abstract][Full Text] [Related]
13. The higher level of complexity of K-Ras4B activation at the membrane. Jang H; Banerjee A; Chavan TS; Lu S; Zhang J; Gaponenko V; Nussinov R FASEB J; 2016 Apr; 30(4):1643-55. PubMed ID: 26718888 [TBL] [Abstract][Full Text] [Related]
14. Markov State Models and Molecular Dynamics Simulations Reveal the Conformational Transition of the Intrinsically Disordered Hypervariable Region of K-Ras4B to the Ordered Conformation. Zhang H; Ni D; Fan J; Li M; Zhang J; Hua C; Nussinov R; Lu S J Chem Inf Model; 2022 Sep; 62(17):4222-4231. PubMed ID: 35994329 [TBL] [Abstract][Full Text] [Related]
15. K-Ras G-domain binding with signaling lipid phosphatidylinositol (4,5)-phosphate (PIP2): membrane association, protein orientation, and function. Cao S; Chung S; Kim S; Li Z; Manor D; Buck M J Biol Chem; 2019 Apr; 294(17):7068-7084. PubMed ID: 30792310 [TBL] [Abstract][Full Text] [Related]
16. Insight into the mechanism of allosteric activation of PI3Kα by oncoprotein K-Ras4B. Li X; Dai J; Ni D; He X; Zhang H; Zhang J; Fu Q; Liu Y; Lu S Int J Biol Macromol; 2020 Feb; 144():643-655. PubMed ID: 31816384 [TBL] [Abstract][Full Text] [Related]
17. Regulation of K-Ras4B Membrane Binding by Calmodulin. Sperlich B; Kapoor S; Waldmann H; Winter R; Weise K Biophys J; 2016 Jul; 111(1):113-22. PubMed ID: 27410739 [TBL] [Abstract][Full Text] [Related]
18. PDEδ Binding to Ras Isoforms Provides a Route to Proper Membrane Localization. Muratcioglu S; Jang H; Gursoy A; Keskin O; Nussinov R J Phys Chem B; 2017 Jun; 121(24):5917-5927. PubMed ID: 28540724 [TBL] [Abstract][Full Text] [Related]
19. Facile Synthesis of Boc-Protected Selenocystine and its Compatibility with Late-Stage Farnesylation at Cysteine Site. Zhu PC; Chen YX Protein Pept Lett; 2021; 28(6):603-611. PubMed ID: 33357178 [TBL] [Abstract][Full Text] [Related]
20. High affinity for farnesyltransferase and alternative prenylation contribute individually to K-Ras4B resistance to farnesyltransferase inhibitors. Fiordalisi JJ; Johnson RL; Weinbaum CA; Sakabe K; Chen Z; Casey PJ; Cox AD J Biol Chem; 2003 Oct; 278(43):41718-27. PubMed ID: 12882980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]